Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. 1983

E A Grimm, and R J Robb, and J A Roth, and L M Neckers, and L B Lachman, and D J Wilson, and S A Rosenberg

Purified interleukin 2 (IL-2) was found to be sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer (LAK) cells. The LAK activation factor was directly and consistently associated with IL-2 activity using classic protein purification techniques, adsorption to IL-2-dependent cell lines, and inhibition with anti-Tac antibody. As yet, no other cytokines have been found that perform the same role.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D013234 Stem Cells Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells. Colony-Forming Units,Mother Cells,Progenitor Cells,Colony-Forming Unit,Cell, Mother,Cell, Progenitor,Cell, Stem,Cells, Mother,Cells, Progenitor,Cells, Stem,Colony Forming Unit,Colony Forming Units,Mother Cell,Progenitor Cell,Stem Cell

Related Publications

E A Grimm, and R J Robb, and J A Roth, and L M Neckers, and L B Lachman, and D J Wilson, and S A Rosenberg
June 1982, The Journal of experimental medicine,
E A Grimm, and R J Robb, and J A Roth, and L M Neckers, and L B Lachman, and D J Wilson, and S A Rosenberg
September 1986, The Journal of experimental medicine,
E A Grimm, and R J Robb, and J A Roth, and L M Neckers, and L B Lachman, and D J Wilson, and S A Rosenberg
March 1983, The Journal of experimental medicine,
E A Grimm, and R J Robb, and J A Roth, and L M Neckers, and L B Lachman, and D J Wilson, and S A Rosenberg
August 1998, Cancer immunology, immunotherapy : CII,
E A Grimm, and R J Robb, and J A Roth, and L M Neckers, and L B Lachman, and D J Wilson, and S A Rosenberg
June 1989, European journal of immunology,
E A Grimm, and R J Robb, and J A Roth, and L M Neckers, and L B Lachman, and D J Wilson, and S A Rosenberg
May 1989, Journal of immunology (Baltimore, Md. : 1950),
E A Grimm, and R J Robb, and J A Roth, and L M Neckers, and L B Lachman, and D J Wilson, and S A Rosenberg
July 1995, International journal of immunopharmacology,
E A Grimm, and R J Robb, and J A Roth, and L M Neckers, and L B Lachman, and D J Wilson, and S A Rosenberg
January 1990, Scandinavian journal of immunology,
E A Grimm, and R J Robb, and J A Roth, and L M Neckers, and L B Lachman, and D J Wilson, and S A Rosenberg
January 1988, The Journal of experimental medicine,
E A Grimm, and R J Robb, and J A Roth, and L M Neckers, and L B Lachman, and D J Wilson, and S A Rosenberg
March 1989, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!